Article
A fluid biomarker accurately detects tau aggregate pathology in Alzheimer's disease - Nature Medicine
Rating:
0.0
Views:
77
Likes:
1
Library:
1
Cost-effective fluid biomarkers for tau aggregate pathology would improve the diagnostic and prognostic work-up of Alzheimer's disease and facilitate the discovery of anti-tau therapies. We identified MTBR-tau243 as a specific marker for tau aggregate pathology that could be implemented in clinical practice and trials.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value